Innovative use of therapeutic antibodies in lung cancer: the current landscape of ADCs and other antibody-based therapies - Top-Institutions - MDSpire

Innovative use of therapeutic antibodies in lung cancer: the current landscape of ADCs and other antibody-based therapies

  • By

  • Matthew Lee

  • Christine M. Lovly

  • July 8, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    University of Texas MD Anderson Cancer Center
    University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Oncology

Original Source(s)

Innovative use of therapeutic antibodies in lung cancer: the current landscape of ADCs and other antibody-based therapies

  • by Matthew Lee, Christine M. Lovly

  • July 8, 2026

Related Content

Hope is everything – an hermeneutic phenomenological study on the lived experiences of individuals with adrenocortical carcinoma

AI Framework Helps Identify New CAR T Target

A human-in-the-loop AI strategy helped narrow more than 10,000 candidates to a CAR T target now validated in mouse models

  • July 6, 2026

  • 3 min
The use of motion tracking technology to support an exercise intervention for children and young people with cancer: perspectives of users and healthcare professionals in the FORTEe trial